Joinn Laboratories (China) Co (SHSE:603127) Common Stock: ¥749 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603127 Joinn Laboratories (China) Co Ltd SHSE:603127
76 GF Score
Price ¥51.30
GF Value ¥17.54
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Joinn Laboratories (China) Co Common Stock?

Joinn Laboratories (China) Co SHSE:603127 -1.16% 76 Common Stock is ¥749 Mil as of Mar. 2026. GuruFocus rates SHSE:603127 with a GF Score™ of 76/100 and a GF Value™ of ¥17.54 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Joinn Laboratories (China) Co's quarterly common stock stayed the same from Sep. 2025 (¥749 Mil) to Dec. 2025 (¥749 Mil) but then declined from Dec. 2025 (¥749 Mil) to Mar. 2026 (¥749 Mil).

Joinn Laboratories (China) Co's annual common stock declined from Dec. 2023 (¥750 Mil) to Dec. 2024 (¥749 Mil) but then stayed the same from Dec. 2024 (¥749 Mil) to Dec. 2025 (¥749 Mil).

Joinn Laboratories (China) Co Common Stock Historical Data

* Premium members only.

The historical data trend for Joinn Laboratories (China) Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Joinn Laboratories (China) Co Common Stock Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 381.25 535.68 749.89 749.48 749.48

Joinn Laboratories (China) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 749.48 749.48 749.48 749.48 749.35
SHSE:603127
76GF Score
Joinn Laboratories (China) Co Ltd SHSE:603127
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Joinn Laboratories (China) Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ¥749 Mil mean?
Joinn Laboratories (China) Co (SHSE:603127) has a Common Stock of ¥749 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Joinn Laboratories (China) Co and its competitors.
Is Joinn Laboratories (China) Co's Common Stock too high?
Joinn Laboratories (China) Co's current Common Stock is ¥749 Mil. Overall, Joinn Laboratories (China) Co has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Joinn Laboratories (China) Co's Common Stock compare to TMO and DHR?
Joinn Laboratories (China) Co's Common Stock of ¥749 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Joinn Laboratories (China) Co and its competitors. Joinn Laboratories (China) Co's current Common Stock is ¥749 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joinn Laboratories (China) Co stock overvalued right now?
Based on GuruFocus' analysis, Joinn Laboratories (China) Co (SHSE:603127) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.54, compared to a current price of ¥51.30 — trading 192.5% above its estimated fair value. The current Common Stock is ¥749 Mil. Joinn Laboratories (China) Co's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Joinn Laboratories (China) Co (SHSE:603127), the current Common Stock is ¥749 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Joinn Laboratories (China) Co (SHSE:603127) Overvalued in 2026?

Based on GuruFocus' analysis, Joinn Laboratories (China) Co stock appears to be overvalued. The current stock price of ¥51.30 is trading 192.5% above its estimated GF Value™ of ¥17.54. GuruFocus considers Joinn Laboratories (China) Co to be Significantly Overvalued.

Key valuation signals for SHSE:603127:

  • Common Stock: ¥749 Mil
  • GF Value™: ¥17.54 vs. price of ¥51.30 (192.5% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603127 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Joinn Laboratories (China) Co Business Description

Other Exchanges 06127:Hong Kong
Address A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a PRC-based company, along with its subsidiary, it is engaged in contract research organisation (CRO) services. It operates in three segments: Non-clinical studies services offer drug safety assessment, drug metabolism and pharmacokinetics (DMPK) studies, and pharmacology and efficacy studies; Clinical trial & related services provide clinical CRO services, co-managed phase I clinical research units, and bioanalytical servicesl services; and Sales of research models engages in the design, production, breeding and sales of research models, non-human primates and rodents. The majority of revenue comes from the Non-Clinical studies services. Its geographical areas are China, the United States, and Other countries, of which the majority are from China.
76GF Score

Get the complete analysis for SHSE:603127

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥51.30
Price
¥17.54
GF Value